Olmesartan Medoxomil
Product Images NDC 71335-2569

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 71335-2569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4e9e1f50 D433 4510 Bc9c 106303e53a49 01)

Image (4e9e1f50 D433 4510 Bc9c 106303e53a49 01)
Chemical structure of Olmesartan Medoxomil, showing a complex molecular structure with multiple rings, ester groups, and functional moieties consistent with this active ingredient.*
FDA Label Image

Image Description (4e9e1f50 D433 4510 Bc9c 106303e53a49 02)

Image Description (4e9e1f50 D433 4510 Bc9c 106303e53a49 02)
A line graph showing the reduction in systolic and diastolic blood pressure (BP) in mmHg by dose of Olmesartan Medoxomil tablets in mg. The x-axis represents the dose (0 to 80 mg), and the y-axis shows the reduction in BP (0 to 14 mmHg). The graph contains two lines: one for systolic BP reduction and another for diastolic BP reduction, demonstrating increasing BP reduction with higher doses.*
FDA Label Image

Label (Lbl713352569)

Label (Lbl713352569)
Olmesartan Medoxomil Tablets USP 5 mg label shows the product's NDC 71335-2569-1. It is repackaged by Bryant Ranch Prepack, Inc., and manufactured by Inventia Healthcare Limited. The label includes storage instructions, a warning to keep out of reach of children, and a note to consult a physician if pregnant. The package contains 90 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.